Melanocyte protein PMEL;gp100;pmel 17
Melanocyte protein Pmel 17 precursor (44-57) is a synthetic peptide fragment derived from the Pmel 17 protein, a key structural component involved in melanosome biogenesis within melanocytes. This segment corresponds to amino acids 44 through 57 of the precursor protein, a region implicated in the early stages of melanosomal fibril formation and pigment deposition. The peptide's sequence captures a biologically relevant motif that is essential for understanding the functional architecture of Pmel 17 and its role in pigmentation pathways. As a research tool, it provides a defined substrate for dissecting the molecular mechanisms underlying melanosome maturation, protein-protein interactions, and the assembly of amyloid-like fibrils specific to pigment cells.
Peptide functional studies: Researchers utilize the Pmel 17 (44-57) peptide to investigate the biochemical processes that govern fibril formation within melanosomes. By serving as a model substrate, the peptide enables detailed analysis of the nucleation and elongation phases of amyloid fibril assembly, which are crucial for the structural integrity of mature melanosomes. Its defined sequence allows for the systematic evaluation of sequence determinants that modulate amyloidogenicity, providing valuable insights into the physicochemical factors driving protein aggregation in pigment cells.
Antibody epitope mapping: The defined sequence of this peptide fragment makes it an ideal reagent for mapping epitopes recognized by antibodies against Pmel 17. Immunologists and protein chemists employ the peptide in binding assays, such as ELISA or Western blot, to characterize antibody specificity and affinity. This application supports the development and validation of immunological tools for detecting Pmel 17 in cellular lysates, tissue sections, or biochemical assays, thereby advancing the study of melanocyte biology and pigment cell markers.
Protein-protein interaction analysis: The Pmel 17 (44-57) region is implicated in mediating interactions with other melanosomal proteins and chaperones. Utilizing the synthetic peptide in pull-down assays, surface plasmon resonance, or other biophysical approaches allows researchers to characterize binding partners and interaction interfaces. Such studies contribute to a deeper understanding of the molecular machinery orchestrating melanosome maturation and the spatial organization of pigment biosynthetic complexes.
Peptide synthesis and assay development: The availability of a well-defined Pmel 17-derived peptide supports the development of custom analytical assays and the optimization of peptide synthesis protocols. Researchers can employ it as a standard or control in mass spectrometry-based quantification, HPLC analysis, or peptide stability studies. Its use in method development ensures the reliability of analytical workflows targeting pigment cell proteins or related biomolecules.
Cellular uptake and trafficking studies: The Pmel 17 (44-57) peptide serves as a valuable probe for examining peptide internalization, intracellular trafficking, and localization within melanocytes or model cell lines. By labeling the peptide with fluorescent or affinity tags, investigators can monitor its uptake dynamics and subcellular distribution using microscopy or flow cytometry. These studies shed light on the pathways governing peptide transport and processing in pigment cells, further elucidating the cellular mechanisms that underpin melanosome function and biogenesis.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More